Fenoldopam: effect on aldosterone secretion.
作者信息
Dupont A G, Vanderniepen P, Volckaert A, Smitz J, Vansteirteghem A C, Six R O
出版信息
Br J Clin Pharmacol. 1986 Feb;21(2):243-4. doi: 10.1111/j.1365-2125.1986.tb05185.x.
Abstract
摘要
相似文献
1
Fenoldopam: effect on aldosterone secretion.非诺多泮：对醛固酮分泌的影响。
Br J Clin Pharmacol. 1986 Feb;21(2):243-4. doi: 10.1111/j.1365-2125.1986.tb05185.x.
2
Effect of fenoldopam on the aldosterone response to metoclopramide in man.非诺多泮对人体中醛固酮对甲氧氯普胺反应的影响。
Clin Endocrinol (Oxf). 1986 Feb;24(2):203-8. doi: 10.1111/j.1365-2265.1986.tb00763.x.
3
The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.
Clin Pharmacol Ther. 1987 Mar;41(3):282-8. doi: 10.1038/clpt.1987.29.
4
A new oral renal vasodilator, fenoldopam.
Clin Pharmacol Ther. 1983 Sep;34(3):309-15. doi: 10.1038/clpt.1983.173.
5
Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.非诺多泮对清醒自发性高血压大鼠局部血管阻力的影响。
J Pharmacol Exp Ther. 1986 Jan;236(1):187-91.
6
The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.多巴胺（DA1）受体激动剂非诺多泮在人体血管系统中的体内及体外作用。
Br J Clin Pharmacol. 1986 Nov;22(5):535-40. doi: 10.1111/j.1365-2125.1986.tb02932.x.
7
[Effects of intravenous administration of fenoldopam on blood pressure and renal function in severe arterial hypertension].[静脉注射非诺多泮对重度动脉高血压患者血压及肾功能的影响]
Med Clin (Barc). 1988 Oct 15;91(12):445-8.
8
Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.使用多巴胺受体DA1激动剂非诺多泮治疗原发性高血压的研究。
Br J Clin Pharmacol. 1986 Jan;21(1):53-61. doi: 10.1111/j.1365-2125.1986.tb02822.x.
9
Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.大鼠中多巴胺、DPDA、非诺多泮和喹吡罗诱导的肾血流动力学变化的选择性拮抗作用。
Proc West Pharmacol Soc. 1987;30:25-36.
10
Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.多巴胺1受体激动剂静脉注射非诺多泮在高血压患者中的药代动力学和药效学特性。
Br J Clin Pharmacol. 1988 Jan;25(1):17-21. doi: 10.1111/j.1365-2125.1988.tb03276.x.
本文引用的文献
1
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.甲氧氯普胺诱导的人体醛固酮分泌的多巴胺能抑制作用。对多巴胺和溴隐亭反应的解离。
J Clin Invest. 1980 Jul;66(1):10-8. doi: 10.1172/JCI109822.
2
Tonic dopaminergic suppression of plasma aldosterone.多巴胺能对血浆醛固酮的张力性抑制作用。
J Clin Endocrinol Metab. 1980 Jul;51(1):64-9. doi: 10.1210/jcem-51-1-64.
3
Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade.
J Clin Endocrinol Metab. 1981 Jun;52(6):1078-84. doi: 10.1210/jcem-52-6-1078.
4
Metoclopramide. An updated review of its pharmacological properties and clinical use.甲氧氯普胺。对其药理特性及临床应用的最新综述。
Drugs. 1983 May;25(5):451-94. doi: 10.2165/00003495-198325050-00002.
5
The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.外周多巴胺受体激动剂口服非诺多泮（SKF 82526-J）对正常男性血压及肾功能的影响。
Br J Clin Pharmacol. 1985 Jan;19(1):21-7. doi: 10.1111/j.1365-2125.1985.tb02608.x.
Zotero 插件